These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35130644)

  • 1. [Rethinking of institutional reform and development of disease control and prevention system in post COVID-19 epidemic era in China].
    Shen HB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Jan; 43(1):1-4. PubMed ID: 35130644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population migration, spread of COVID-19, and epidemic prevention and control: empirical evidence from China.
    Hu Z; Wu Y; Su M; Xie L; Zhang A; Lin X; Nie Y
    BMC Public Health; 2021 Mar; 21(1):529. PubMed ID: 33731053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "A community system": A critical foundation for the epidemic prevention and control of SARS-CoV-2.
    Zhang X; Yang S
    Int J Health Plann Manage; 2020 Sep; 35(5):1246-1249. PubMed ID: 32677114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and control mechanism for coronavirus disease 2019 epidemic at the primary level: perspective from China.
    Zhang X; Wang Y
    Epidemiol Infect; 2020 Jul; 148():e161. PubMed ID: 32713366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turning rural villages into the home front for social stability-Examination of coronavirus disease 2019 control experiences in rural areas in China.
    Zhang X; Xiang C
    Int J Health Plann Manage; 2020 Sep; 35(5):1250-1256. PubMed ID: 32677128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public Health Crises In Comparison: China's Epidemic Response Policies From SARS To COVID-19.
    Li M
    Glob Public Health; 2021; 16(8-9):1223-1236. PubMed ID: 33891518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous focus on COVID-19 epidemic: Changes in China's clinical guidance.
    Wang QC; Wang ZY
    Int J Clin Pract; 2021 Mar; 75(3):e13869. PubMed ID: 33264484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The dynamic COVID-zero strategy on prevention and control of COVID-19 in China].
    Liang WN; Liu M; Liu J; Wang YD; Wu J; Liu X
    Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(4):239-242. PubMed ID: 35073672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. China's model to combat the COVID-19 epidemic: a public health emergency governance approach.
    Ning Y; Ren R; Nkengurutse G
    Glob Health Res Policy; 2020; 5():34. PubMed ID: 32685691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding public health in China: an empirical analysis of healthcare inputs and outputs.
    Deng F; Lv JH; Wang HL; Gao JM; Zhou ZL
    Public Health; 2017 Jan; 142():73-84. PubMed ID: 28057203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.
    Huang M; Wang J; Nicholas S; Maitland E; Guo Z
    J Med Internet Res; 2021 Jun; 23(6):e27345. PubMed ID: 34061761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to the COVID-19 Epidemic: The Chinese Experience and Implications for Other Countries.
    Liu W; Yue XG; Tchounwou PB
    Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32235413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of China's public health system response to COVID-19.
    Zhang P; Gao J
    J Glob Health; 2021 Jan; 11():05004. PubMed ID: 33643637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the Experience of Public Health System Construction in China's COVID-19 Prevention.
    Zhang P
    Front Public Health; 2021; 9():610824. PubMed ID: 33981659
    [No Abstract]   [Full Text] [Related]  

  • 15. The Influence of the COVID-19 Epidemic on Prevention and Vaccination Behaviors Among Chinese Children and Adolescents: Cross-sectional Online Survey Study.
    Hou Z; Song S; Du F; Shi L; Zhang D; Lin L; Yu H
    JMIR Public Health Surveill; 2021 May; 7(5):e26372. PubMed ID: 33882450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of China's Prevention and Control Strategy for the COVID-19 Epidemic.
    Wang J; Wang Z
    Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32225019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traffic control and social distancing evidence from COVID-19 in China.
    Lin S; Lin R; Yan N; Huang J
    PLoS One; 2021; 16(6):e0252300. PubMed ID: 34077487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systematic review on the reform of disease prevention and control system in China].
    Liang MX; Yuan SS; Shao ZJ; Tian F; Zhang ZW; Han K; Lyu XZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Nov; 55(11):1332-1338. PubMed ID: 34749478
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemiological characteristics of three local epidemics of COVID-19 in Guangzhou].
    Zhao WH; Ma Y; Wang H; Li K; Dong H; Liu WH; Liu YY; Jiang SQ; Luo L; Yang ZC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Dec; 42(12):2088-2095. PubMed ID: 34954969
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of Big Data Technology for COVID-19 Prevention and Control in China: Lessons and Recommendations.
    Wu J; Wang J; Nicholas S; Maitland E; Fan Q
    J Med Internet Res; 2020 Oct; 22(10):e21980. PubMed ID: 33001836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.